This vehicle-controlled animal study (n=24) investigated the effects of esketamine (4.5mg/0.3kg) on astrocyte plasticity in the hippocampus of a depression-model rat strain. Results indicate that ketamine can rapidly modify the shape of astrocytes (sub-type of glial cells) so that they can optimally modulate the synaptic micro-environment, neurogenesis, and vascularization, which is otherwise impaired under depression.
Background and purpose: Astroglia contribute to the pathophysiology of major depression and antidepressant drugs act by modulating synaptic plasticity; therefore, the present study investigated whether the fast antidepressant action of ketamine is reflected in a rapid alteration of the astrocytes’ morphology in a genetic animal model of depression.Experimental Approach: S-Ketamine (15 mg·kg−1) or saline was administered as a single injection to Flinders Line (FSL/ FRL) rats. Twenty-four hours after the treatment, perfusion fixation was carried out and the morphology of glial fibrillary acid protein (GFAP)-positive astrocytes in the CA1 stratum radiatum (CA1.SR) and the molecular layer of the dentate gyrus (GCL) of the hippocampus was investigated by applying stereological techniques and analysis with Imaris software. The depressive-like behaviour of animals was also evaluated using forced swim test.Key Results: FSL rats treated with ketamine exhibited a significant reduction in immobility time in comparison with the FSL-vehicle group. The volumes of the hippocampal CA1.SR and GCL regions were significantly increased 1 day after ketamine treatment in the FSL rats. The size of astrocytes in the ketamine-treated FSL rats was larger than those in the FSL-vehicle group. Additionally, the number and length of the astrocytic processes in the CA1.SR region were significantly increased 1 day following ketamine treatment.Conclusions and Implications: Our results support the hypothesis that astroglial atrophy contributes to the pathophysiology of depression and a morphological modification of astrocytes could be one mechanism by which ketamine rapidly improves depressive behaviour.
Papers cited by this study that are also in Blossom
Dutta, A., Mckie, S., Deakin, J. F. W. · Psychiatry Research (2014)
Monteggia, L. M., Zarate, C. A. · Current Opinion in Neurobiology (2015)
Serafini, G., Howland, R. H., Rovedi, F. et al. · Current Neuropharmacology (2014)
Papers in Blossom that reference this study
Liu, F., Gong, Y., Wang, P. et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017)
Major depressive disorder is associated with structural plasticity changes in the hippocampus, and growing evidence implicates glial cells—particularly astrocytes—in the pathophysiology of depression. Astrocytes support neuronal function by supplying energy, recycling neurotransmitters and interacting with the vasculature, and preclinical work has reported stress‑related reductions in astrocyte number and soma volume in the hippocampus that may be reversed by some antidepressants. Conventional antidepressants are limited by slow onset and incomplete efficacy, whereas clinical studies show that ketamine, an NMDA receptor antagonist, can rapidly reduce depressive symptoms and suicidal ideation within hours. This study by Ardalan and colleagues set out to test whether ketamine’s rapid antidepressant-like effects are accompanied by acute morphological changes in hippocampal astrocytes. Using a genetic rat model of depression (Flinders sensitive line, FSL) and corresponding controls (Flinders resistant line, FRL), the investigators examined behaviour and multiple stereological and three-dimensional measures of astrocyte and hippocampal subregion structure 24 hours after a single dose of S‑ketamine.
Adult male Flinders sensitive line (FSL; n = 12) and Flinders resistant line (FRL; n = 12) rats were used. Animals were pair‑housed under standard conditions and all procedures complied with Danish animal ethics guidelines and the ARRIVE recommendations. Four experimental groups (n = 6 per group) were formed: FRL.vehicle, FRL.ketamine, FSL.vehicle and FSL.ketamine. Rats received a single intraperitoneal injection of S‑ketamine hydrochloride (15 mg•kg−1) or saline and were euthanised 24 hours later. Behavioural assessment used a modified forced swim test performed 30 minutes before perfusion (≈23.5 h post‑injection); immobility and mobility were categorised as previously described. For histology, animals were perfused and brains were sectioned coronally at 40 μm. One series of sections was Nissl stained for volumetric stereology and another series was immunostained for glial fibrillary acidic protein (GFAP) to visualise astrocytes. Hemisphere and initial section were chosen randomly and sampling followed a systematic principle (section sampling fraction 1/12). The volumes of two hippocampal subregions—CA1 stratum radiatum (CA1.SR) and the granular cell layer (GCL) of the dentate gyrus—were estimated on Nissl sections using the Cavalieri estimator with point counting. GFAP‑positive astrocytes in CA1.SR and the molecular layer of the dentate gyrus were analysed. For detailed morphology, Z‑stacks (20–25 μm, 0.5 μm steps) of GFAP sections were acquired with a 60× oil objective and reconstructed in Imaris (Filament Tracer) to quantify branch number, total branch length, branch area and Sholl intersections. Morphological reconstructions used 30 GFAP+ astrocytes per animal in CA1.SR selected by predefined criteria (soma centrally located in section thickness, intact and unobscured processes). Astrocyte soma volume was estimated with a 3D nucleator on GFAP sections (100× oil objective), sampling ~50–80 astrocytes per animal using an optical disector height of 15 μm and six half‑lines in a vertical uniform random (VUR) mode. The same blinded investigator performed all quantifications. Statistical analyses used two‑way ANOVA (strain × treatment) with post hoc Bonferroni tests and Pearson correlations; significance was P < 0.05.
In the forced swim test there was a significant strain × treatment interaction (F1,20 = 6.32; P < 0.05), a main effect of strain (F1,20 = 54.73; P < 0.05) and of ketamine treatment (F1,20 = 5.96; P < 0.05). FSL‑vehicle animals showed greater immobility than FRL‑vehicle controls, and a single ketamine injection produced a significant reduction in immobility in FSL rats at 24 hours (P < 0.05). Stereological measures showed that GFAP‑positive astrocyte volume in CA1.SR was influenced by strain (F1,20 = 19.23; P < 0.05) and ketamine treatment (F1,20 = 6.97; P < 0.05). Astrocyte soma volume in CA1.SR and in supra‑ and infra‑molecular layers of the dentate gyrus (MDG) was smaller in FSL‑vehicle than FRL‑vehicle rats (P < 0.05). Ketamine increased astrocyte volume in the supra‑ and infra‑MDG and produced a significant augmentation of astrocyte volume in CA1.SR of FSL rats at 24 hours (P < 0.05). Pearson correlations linked CA1.SR regional volume with astrocyte size (r = 0.60; P < 0.05) and astrocyte volume with total process length (r = 0.65; P < 0.05). Applying the Cavalieri estimator, CA1.SR and GCL regional volumes were significantly larger in FRL‑vehicle than FSL‑vehicle rats (P < 0.05), and both CA1.SR and GCL volumes increased markedly in FSL rats one day after a single ketamine injection (P < 0.05). For astrocytic morphology in CA1.SR, total process length showed a strain × treatment interaction (F1,20 = 11.79; P < 0.05); FSL‑vehicle and FRL‑vehicle differed (P < 0.05), and ketamine significantly increased total branch length in both strains (P < 0.05). Total process length correlated strongly with CA1.SR volume (r = 0.835; P < 0.05) and was negatively correlated with immobility time (r = −0.64; P < 0.05). The total number of astrocytic branches was affected by strain (F1,20 = 22.01; P < 0.05), treatment (F1,20 = 97.79; P < 0.05) and their interaction (F1,20 = 7.74; P < 0.05). Mean branch counts were higher in FRL than FSL (31 ± 2.4 vs 24 ± 2.1; P < 0.05). Ketamine increased branching in both strains (FSL: 24 ± 2.1 to 38 ± 1.8; FRL: 31 ± 2.4 to 41 ± 5.3; P < 0.05). Branch number correlated with CA1.SR volume (r = 0.78; P < 0.05) and was negatively associated with immobility (r = −0.61; P < 0.05). Sholl analysis revealed that FSL‑vehicle astrocytes had fewer intersections at 10 μm and 20 μm from the soma compared with FRL‑vehicle (P < 0.05). Acute ketamine treatment in FSL rats increased branch length at 10, 20 and 30 μm from the cell body (P < 0.05), while intersections at 40 μm were unchanged (P > 0.05). Overall, ketamine produced rapid increases in astrocyte size, branching and regional hippocampal volumes that paralleled the behavioural antidepressant‑like effect.
Ardalan and colleagues interpret their findings as evidence that ketamine rapidly modulates astroglial structural plasticity in the hippocampus within 24 hours, in parallel with a potent antidepressant‑like behavioural effect. The observed baseline deficits in hippocampal subregion and astrocyte size in the FSL depression model are consistent with earlier human and animal studies showing hippocampal volume reductions in depression. In this study a single S‑ketamine dose enlarged CA1.SR and GCL regional volumes and increased astrocyte soma size, branch number and branch length, particularly in FSL animals. The authors discuss several mechanistic pathways that could link ketamine to astrocyte structural change. These include rapid glutamate release and activation of astrocytic calcium signalling, astrocyte‑derived D‑serine contributing to NMDA receptor function, and effects on GFAP and glutamate transporters that influence synaptic glutamate handling. They also highlight astrocyte production of neurotrophic and angiogenic factors such as BDNF and VEGF as potential mediators of synaptogenesis, neurogenesis and microvascular changes. Ardalan and colleagues note consistency with their prior work showing increased excitatory synapse number in CA1.SR 24 hours after ketamine and a sustained synaptic effect at one week, suggesting coordinated neuronal and astroglial remodelling. The discussion acknowledges that previous studies of conventional antidepressants such as fluoxetine have reported mixed results regarding astrocyte morphology, indicating some uncertainty in the literature about how different treatments affect astrocytes over various timeframes. The authors propose that rapid astrocyte activation and hypertrophy, with consequent increases in trophic signalling and restored astrocyte–neuron–vascular interactions, could be one mechanism contributing to ketamine’s fast therapeutic actions. They further suggest that changes in astrocyte morphology may restore activity‑dependent vasodilation and support neurogenesis. The extracted text does not present a detailed limitations paragraph specific to this experiment, although the authors note the existence of contradictory findings in related studies and frame several mechanistic explanations as hypotheses requiring further study.
The investigators conclude that morphological impairment of hippocampal astrocytes likely contributes to depression pathogenesis and that one mechanism underlying ketamine’s rapid antidepressant effect is its ability to modify astrocyte morphology. By hypertrophying and increasing the arborisation of astrocytes, ketamine may better enable these cells to regulate the synaptic micro‑environment, support neurogenesis and influence hippocampal vascularisation, thereby contributing to behavioural improvement.
Major depressive disorder is a serious and costly psychiatric condition, and severe depression with suicidal ideation is a particular concern in the treatment of depression. The plasticity of the hippocampal structure is believed to be one of the central mechanisms underlying severe depression. Importantly, glial cells play a dynamic role in modifying brain structureand significantly, clinical and preclinical observations converge on the hypothesis that the structural changes as well as the functional abnormality of glial cells contribute to the pathophysiology of major depression. Cotter and co-workers observed a reduction in glial cell density in the frontal cortex of patients with major depressive disorder. Specifically, one of the different types of glial cells, astrocytes play a key role in the maintenance of brain homeostasis, supplying energy to the neurons, recycling neurotransmitters, and by connecting to the blood vessels promoting their development. In particular, astrocytes participate in a dynamic structural framework for supporting synaptic function. Earlier findings have shown that astrocytes significantly contribute to the regulation of the function of the excitatory glutamate synapses in the hippocampus. Interestingly, preclinical studies suggested that stress decreases the number and volume of astroglia soma in the hippocampus, an effect which may be reversed by fluoxetine. Therefore, it is most likely that the therapeutic effect of conventional antidepressant drugs is not only as a consequence of the modification of neuronal plasticity but also as a result of a change in the morphology and number of astrocytes, which subsequently affects synaptogenesis, synaptic strength and stability. Currently, the treatment of major depression is not ideal due to the slow onset of action and only partial therapeutic effect of traditional antidepressant drugs. Clinical studies from the last decade indicate that ketamine; primarily acting on the glutamatergic NMDA receptor, quickly (within hours) improves depressive symptoms especially suicidal ideation in patients with treatment-resistant depression. However, several novel undiscovered mechanisms of action of the rapid-acting interventions exist and identification of more specific targets related to the fast antidepressant effect of ketamine could help in the development of novel antidepressant treatments with a fast action and fewer side effects. Accordingly, in the current study, we sought to examine the assumption that an alteration in glial plasticity, especially of astrocytes, may be evident in the acute (24 h) phase following the administration of ketamine.
This study was performed on an adult male Flinders sensitive line (FSL), a genetic animal model of depression, with a Flinders resistant line (FRL) rats (FSL, n = 12; FRL, n = 12) as the control group. The FSL/FRL animals, originating from the colonies at Karolinska Institute (Sweden) and University of North Carolina (NC, USA), were bred at the Translational Neuropsychiatry Unit, Aarhus University, Denmark. The average age of the animals was 95 days. All animal care and procedures were carried out in accordance with the guidelines issued by the Danish national committee on animal ethics (permission id 2012-15-2934-00254). Animals were pairwise housed in groups of two in a temperature-controlled environment (20-22°C), having a normal 12 h light : dark cycle (lights on at 06:00). The animals had free access to food and water. Animal studies are reported in compliance with the ARRIVE guidelines.
Four experimental groups were set up: FRL.vehicle (n = 6), FRL.ketamine (n = 6), FSL.vehicle (n = 6) and FSL.ketamine (n = 6). S-Ketamine hydrochloride (5 mg•mL À1 , Pfizer ApS, Denmark, ATC-code N01AX14) was obtained from the local hospital pharmacy. Rats received a single i.p. injection of ketamine or saline (15 mg•kg À1 )and were perfused 24 h after treatment as described below.
Depression-like behaviour of the rats was assessed by the modified forced swim test30 min before transcardial perfusion (i.e. 23.5 h after the injection). The behavioural pattern of animals was categorized according to mobility and immobility (floating) as described previously.
The procedures were as described previously. Briefly, the rats were anaesthetised deeply with an i.p. injection of pentobarbital sodium/lidocaine, and were subsequently perfused with heparin (10 U•mL À1 )-treated 0.9% saline (pH = 7.3) for 4 min, followed by ice-cold 4% paraformaldehyde (pH = 7.2-7.4) for 7 min. The right or left hemisphere was selected randomly, and they were placed in a cryoprotective solution containing 30% (w . v -1 ) sucrose for 48 h, followed by placement on the copper blocks and frozen in the liquid nitrogen. Brains were then cut coronally at 40 μm thickness on a cryostat (Leica, Germany). The first section of each series was assigned randomly by using a random table, and two sets of sections were chosen based on a systematic sampling principle and a section sampling fraction of 1/12. Therefore, we had 8-10 sections per series with a fixed distance 480 μm (12 × 40). One set of sections was used for thionin staining, and the second one was used for glial fibrillary acid protein (GFAP) staining.
Free-floating sections were washed in Tris buffer saline (TBS) containing 0.1% Triton X-100 for 30 min followed by blocking endogenous peroxidase (30% H 2 O 2 and methanol dissolved in TBS) for 30 min. Antigen retrieval prior to immunohistochemistry was performed by heating the sections in the retrieval solution (Dako, Ref# S1699, Denmark) dissolved in distilled water in the oven for 30 min. Thereafter, sections were washed three times in 1% BSA and 0.3% Triton-X in TBS solution for 10 min. Following this step, sections were incubated with a polyclonal rabbit anti-GFAP (Dako, Ref# Z0334, Denmark) at 1:500 dilutions in 1% BSA, TB buffer 50 mM overnight at 4°C. Subsequently, sections were washed in TBS with 0.1% BSA and Triton X-100 for 10 min, and then incubated in polyclonal secondary goat anti-rabbit IgG antibody/HRP (1:200 dilutions; Dako, Ref# P0448, Denmark) for 2 h. Afterwards, sections were rinsed three times in TBS for 10 min. The immunolabelling was done by using 3,3 0 -diaminobenzidine solution (Sigma, USA) for 1 min. Finally, the sections were mounted on the gelatincoated slides and counterstained with 0.25% thionin solution (thionin, Sigma T3387).
The volumes of two subregions of the rat hippocampus [CA1 stratum radiatum (CA1.SR) and granular cell layer of dentate gyrus (GCL)] were estimated on Nissl-stained sections by applying the Cavalieri estimator with point countingusing the newCAST software (Visiopharm, Hørsholm, Denmark), an Olympus light microscope (Olympus BX50, Olympus, Denmark) modified for stereology with a digital camera (Olympus DP72, Olympus, Denmark), a motorized microscope stage (Prior H138 with controller H29, Cambridge, UK) and a 10× lens (Olympus, Splan, N.A. 0.45). The following formula was used for estimating the volume of hippocampal subregions: where ΣP is the total number of the points hitting the region of interest, (a/p) is the area per point (0.007 mm 2 ), T is the section thickness (40 μm) and SSF is the section sampling fraction (1/12).
A systematic set of Z-stacks of the 40 μm thick GFAP-stained sections of the CA1.SR area was captured by an Olympus scanner VS120 (using software VS-ASW 2.5, Build 9483) by using a 60× oil objective (Olympus, Splan, N.A. 1.35). The advantage of this method of image acquisition was the possibility of Z-stack capturing of more than one astrocyte at the same time. The height of the Z-stacks was 20-25 μm, and the acquisition of images was performed in steps of 0.5 μm (Figure).
The images captured were transferred to Imaris software (Version 7.7, Bitplane A.G., Zurich, Switzerland), and by using the Filament Tracers algorithm, the morphology (number of branches, total length of the branches, area of the branches area and sholl analysis of intersections) of astrocytes was quantified. The centre of the astrocyte soma was used as a reference point, and the length of the processes was measured based on the radial distance from the reference point in 10 μm. The sum of the number of branching intersections for all circles, the intersection of the branches and the circle with the maximal radial distance were measured for each astrocyte. Morphological analysis was performed on 30 GFAP positive astrocytes in the CA1.SR area of the hippocampus from each animal. To obtain a reliable reconstruction, the sampling/selection criteria for the astrocytes were: (i) the cell bodies must be located in the middle of the section thickness with the clear border; (ii) the cell must have intact branches; and (iii) the branches of the selected cell should not be obscured by the branches of nearby cells or the background staining. We used the semi-automatic option in the Filament Tracer module for quantifying the morphology of astrocytes. For 3D reconstruction of astrocytic branches, the diameter of the starting point was determined based on the longest diameter of the cell body. By identifying the branch endpoints and bifurcations, the complexity of the astrocytic branches was quantified (Figure).
The volume of astrocytes was investigated in two subregions of the hippocampus: the CA1.SR and molecular layer of the dentate gyrus (MDG) on GFAP stained sections. Based on the division of GCL along the transverse axis into suprapyramidal blade (located between the CA3 and the CA1 areas) and infra-pyramidal blade (located below the CA3 field), MDG was divided into supra.MDG and infra.MDG areas. The astrocytic volume was calculated by applying 3D nucleator (NewCast Ver 4.1, Visiopharm, Hørsholm, Denmark). The number of half-lines was set at 6, and the mode was vertical uniform random (VUR) based on the assumed rotational symmetry of astrocytes. The volume of GFAPimmunopositive astrocytes was estimated with a 100× oil-immersion objective lens (Olympus, Plan Apochromat, N.A. 1.25) (Figure). We randomly sampled 50-80 astrocytes per animal with the optical disector set at a height of 15 μm. All investigations were performed by the same researcher, who was unaware of the identity of the rat groups.
Statistical analysis of data was performed by using the IBM SPSS Statistics 22 programme and graphs were created by Sigmaplot 12.5 (SYSTAT, San Jose, CA). To compare the behaviour of animals, the volumes of the hippocampal subregions and the morphological alterations of the astrocytes between four groups of animals, two-way ANOVA followed by a post hoc Bonferroni test was employed. For assessing the normal distribution of variables before doing the two-way ANOVA, a Q-Q plot and histogram for each variable was generated. Two tailed Pearson analysis tested for a correlation between the different structural parameters of the hippocampus. A two-tailed probability level of P < 0.05 was used as the significance level. The data and statistical analysis comply with the recommendations on experimental design and analysis in pharmacology.
The animal behaviour in the forced swim test The results from the forced swim test revealed a rapid, clear antidepressant-like effect of ketamine on immobility time, with a strain × treatment interaction (F 1, 20 = 6.32; P < 0.05), a significant effect of strain (F 1, 20 = 54.73; P < 0.05) and ketamine treatment (F 1, 20 = 5.96; P < 0.05). The duration of the immobility time was significantly higher in the FSL-vehicle rats compared to the FRL-vehicle rats. A meaningful decrease in the duration of immobility behaviour in the FSL rats 1 day after a single injection of ketamine was observed (P < 0.05) (Figure).
The stereological investigation showed that the volume of the GFAP positive astrocytes in the CA1.SR area was significantly influenced by strain (F 1, 20 = 19.23; P < 0.05) and ketamine treatment (F 1, 20 = 6.97; P < 0.05). In the FSL.vehicle rats, the volume of astrocytes in the CA1.SR area was significantly smaller than the FRL.vehicle rats (P < 0.05). Similarly, the astrocytes' volume in the supra-and inframolecular layers of the DG was significantly larger in the FRL.vehicle rats compared with the FSL.vehicle rats. Notably, our results showed that astrocytes in the supra-and inframolecular layers of the DG from FSL rats with ketamine treatment are significantly larger in comparison with the FSL rats without treatment (Figure). The results also demonstrated a quantitative augmentation of the volume of astrocytes in the CA1.SR area of the hippocampus 1 day after a single injection of ketamine in FSL rats (P < 0.05) (Figure). Pearson correlation analysis demonstrated a positive correlation between the volume of the CA1.SR subregion and the size of the astrocytes in this area (r = 0.60; P < 0.05). Additionally, we found a positive correlation between the volume of astrocytes and total length of astrocytic processes in the CA1.SR area (r = 0.65; P < 0.05).
By applying the Cavalieri estimator, a significant strain × treatment interaction on the volume of CA1.SR area was found (F 1, 20 = 13.65; P < 0.05). Additionally, a significant influence of ketamine treatment on the volume of the CA1. SR was observed (F 1, 20 = 49.11; P < 0.05). Moreover, a significant influence of strain (F 1, 20 = 4.7; P < 0.05) and treatment (F 1, 20 = 8.42; P < 0.05) on the volume Figure(A) Illustration of the 3D nucleator tool for estimating the volume of GFAP positive astrocytes in the CA1.SR, supra-and infra-MDG subfields of rat hippocampus. Six half-lines (blue half-lines) were used and the intersections between the half-lines and the border of the cell soma were assigned by using a 100× objective. Scale bar is 20 μm; (B) Volume of the astrocytes in the infra-MDG in the FSL and FRL rats 1 day after a single ketamine or saline administration.*P < 0.05; (C) Volume of the astrocytes in the CA1.SR area of the hippocampus in FSL and FRL rats 1 day after a single ketamine or saline administration, *P < 0.05.
Fast effect of a single i.p. injection of ketamine on the immobility behaviour in the forced swim test in the FSL and FRL rats, *P < 0.05. of the GCL was observed. FRL-vehicle rats showed considerably larger CA1.SR and GCL areas compared to those of the FSL-vehicle rats (P < 0.05). These results indicate that the volume of both hippocampal subregions (CA1.SR and GCL) is markedly increased in the FSL rats 1 day after a single injection of ketamine (P < 0.05) (Figure). Rapid effect of ketamine treatment on the morphology of astrocytes in the CA1.SR subregion of the hippocampus Total length of astrocytic processes. Two-way ANOVA showed a significant strain × treatment interaction (F 1, 20 = 11.79; P < 0.05). The total length of the astrocytic processes was significantly different between the FSL.vehicle and FRL. vehicle rats (P < 0.05). Interestingly, 1 day after a single injection of ketamine, the length of the astrocytic branches was significantly increased in the FSL rats and similarly, ketamine had a significant effect on the total length of the astrocytic branches in the FRL rats (P < 0.05). Our results showed a comparable correlation between the total length of the astrocytic processes and the volume of the CA1.SR (r = 0.835; P < 0.05). Furthermore, the total length of the astrocytic processes was negatively correlated with the duration of immobility time (r = À0.64; P < 0.05). Total number of astrocytic processes. The total number of astrocytic branches was influenced significantly by strain (F 1, 20 = 22.01; P < 0.05), treatment (F 1, 20 = 97.79; P < 0.05) and strain × treatment interaction (F 1, 20 = 7.74; P < 0.05). Astrocytes in the CA1.SR area of the hippocampus showed a significantly higher number of branches in the FRL rats in comparison with the FSL rats (31 ± 2.4 vs 24 ± 2.1; P < 0.05). Moreover, ketamine treatment significantly induced branching of astrocytes in the FSL and FRL rats (24 ± 2.1 vs 38 ± 1.8, P <0.05; 31 ± 2.4 vs 41 ± 5.3; P < 0.05). Correlation analysis demonstrated a significant association between the total number of astrocytic branches and the volume of the CA1.SR (r = 0.78; P < 0.05). Furthermore, correlation analysis showed that the duration of the immobility behaviour was negatively correlated with the total number of astrocytic branches (r = À0.610; P < 0.05). Sholl analysis. In this study, sholl analysis revealed that irrespective of ketamine treatment, the branching patterns of astrocytes in the CA1.SR subregion of the hippocampus were significantly different between the FSL.vehicle and the FRL.vehicle rats and taken together; ketamine treatment had a significant effect on the astrocytic arborization in both the FSL and FRL rats 1 day after a single injection. The number of branching intersections 10 μm and 20 μm away from the cell soma were significantly lower in the FSL. vehicle rats compared to the FRL.vehicle rats (P < 0.05); however, no difference was detected between the FSL.vehicle and the FRL.vehicle rats within 30 and 40 μm sholl spheres (P > 0.05). Our results demonstrated that acute ketamine treatment is associated with a significant increase in the length of the astrocytic branches at distances of 10, 20 and 30 μm away from the cell body of astrocytes in the FSL group. The number of intersections within the 40 μm sholl spheres around the cell soma did not change significantly in the FSL rats after ketamine treatment (P > 0.05) (Figure).
The main finding of the present study is that ketamine modulates several structural parameters related to astroglial plasticity in the hippocampus in the following 24 h. These findings go hand-in-hand with the behavioural observations, where ketamine acts as a potent antidepressant. Ketamine has been shown to have behavioural antidepressant-like effects in several other studies (60 min to weeks after the treatment). The recent clinical studies have focused on the rapid reduction of the suicidal ideation in patients with severe depression following a single ketamine administration. Our findings that show ketamine has an ameliorative effect on the immobility behaviour 24 h after a single injection are in agreement with these previous observations. Earlier neuroimaging studies documented that one of the prominent structural alterations in the limbic areas of patients with major depressive disorder is a reduction in the volume of the hippocampus. Our findings are also in agreement with an earlier study from our laboratory, where it was shown that the volume of the hippocampus, in particular subregions of the hippocampus such as the CA1.SR and GCL, is significantly smaller in the FSL rats than the corresponding control group. Intriguingly, results obtained from using a non-rodent model (spontaneously appearance of behavioural depression in captive cynomolgus macaques) suggested that the difference in the anterior hippocampal volume of depressed monkeys primarily was related to the changes in the volume of the CA1 and DG areas. With regard to the effects of interventions, it was elucidated earlier that conventional antidepressant drugs produce a normalization of the structural plasticity of the hippocampus, by altering the volume of the area, the number of cells (for example through decreasing apoptosis or inducing cellular genesis), the volume of the cells and inducing morphological changes of the dendrites and axons. In the present work, we found evidence for the hypothesis that ketamine rapidly alters the volume of the CA1.SR and GCL areas (within 24 h) in the depressed animals. One possible explanation for the larger volume of the GCL in the ketamine-treated animals is an increase in the number of granule cells in this layer as a result of the stimulation of the rate of the neurogenesis without inducing a deficit in the maturation of the newborn neurons. Another explanation could be a reduction in the rate of apoptosis in this area after ketamine treatment. We postulated that in the CA1.SR area, alterations in the morphology of pyramidal cell dendrites, as well as the number and morphology of glial cells could be responsible for normalizing the volume of the area after ketamine treatment. The results of the present study coupled with previous observation on female depressed monkeys all corroborate the hypothesis that a reduction in the volume of the CA1 subregion of the hippocampus is mainly associated with the changes in the number of glial cells and the extent of neuropil in this area. Our results on the structure of astrocytes in the CA1.SR area demonstrate that in depressed animals the morphology of astrocytes including the size of the cells and the branching patterns of astrocytic processes are significantly reduced. It is well documented that the interaction between the astrocytes and neurons is crucial for modulating the excitatory glutamate hippocampal synapses) by regulating the amount of glutamine, an essential factor for releasing neuronal glutamateand D-serine factor (Ben. It has been shown that astrocytic foot processes are the main source of D-serine and that activation of NMDA receptors needs the binding of both glutamate and D-serine. Additionally, it has been demonstrated that intermediate filament protein (GFAP) has an important role in regulating the astrocytic and neuronal glutamate transporter, as a loss of astrocytic GFAP resulted in decreases in the activity of both the astrocytic excitatory amino acid transporter 1 (EAAT1) and neuronal EAAT3. Therefore, it is reasonable to believe that disruption of the morphology of the astrocytes contributes to the pathogenesis of major depression by perturbing synaptic plasticity. The results of the present study indicated that a single dose of ketamine has a rapid conspicuous effect on the soma size and on the astrocytic arborization in the CA1.SR area of the hippocampus in a rat model of depression. This finding is in agreement with previous results showing that astroglial process endings are dynamic and change their morphology rapidly (within minutes). Crucially, one of the principle tasks of the astrocytes is the synthesis and release of neurotrophic factors such as brain-derived neurotrophic factor (BDNF)and the antidepressant effect of traditional antidepressant drugs and ketamine have been shown to be dependent on the hippocampal level of BDNF. Accordingly, one possible explanation for the rapid therapeutic effect of ketamine is the rapid activation of astrocytes and substantial stimulation of BDNF synthesis by activated hypertrophic astrocytes. Additionally, earlier studies tried to identify the role of astrocytes as one of the cellular mechanisms underlying the therapeutic effect of fluoxetine by studying the effect of fluoxetine on the expression of 5-HT receptor subtypes, such as 5-HT 2B , on the astrocytes; they discovered that fluoxetine had a significant effect on the glutamatergic function of astrocytes. However, other studies reported contradictory results on the morphological alterations of astrocytes induced by fluoxetine treatment. For instance,demonstrated that stress reduced the volume of astrocytes in the hippocampus and fluoxetine treatment did not prevent this somal volume shrinkage of astrocytes. We also anticipated that after ketamine administration, glutamate activates astrocytes quickly and as a consequence the concentration of Effect of ketamine treatment 1 day after a single injection on the branching pattern of astrocytes in the CA1.SR subregion of the hippocampus using sholl analysis in the FSL and FRL rats. The number of branching intersections 10 and 20 μm away from the cell soma were significantly lower in the FSL.vehicle rats compared to the FRL.vehicle rats (P < 0.01). Significant increase in the length of the astrocytic branches at 10, 20 and 30 μm away from the cell body of astrocytes in the FSL group 1 day after treatment (P < 0.05). astrocytic Ca 2+ is increased. This enhancement in the intracellular levels of Ca 2+ has a significant effect on the synaptic plasticity. It has been discovered that some distal astrocytic branches and, rarely, astrocytic cell bodies in the cerebral cortex of adult rats contain NMDA receptors. Therefore, it has been suggested that some functions of the NMDA receptor depend on the activation of astrocytic NMDA receptors. Thus, the results of the present study greatly increase our knowledge about the involvement of astrocytes in the fast synaptic plasticity observed after ketamine treatment. Consistent with the results of the present study, we recently published a paper about the stimulation of rapid synaptogenesis by ketamine. We found that 1 day after a single dose of S-ketamine, the number of excitatory synapses in the CA1.SR area of hippocampus significantly increased. Additionally, we observed a significant sustained effect on the synaptic plasticity of the hippocampus 1 week after a single dose of S-ketamine. Parallel with the astrocytic changes in the CA1.SR area, our study showed that the size of the GFAP-positive astrocytes in the MDG in the FSL rats was significantly smaller than that of the control group and ketamine counteracted this effect of depression on the morphology of astrocytes. The cellular modifications in this hippocampal subregion are important, as the microvasculature of the DG is a key contributor to adult hippocampal neurogenesis. There is experimental evidence indicating that angiogenesis and neurogenesis are modulated by the signalling of VEGF, one of the factors expressed by astrocytes in hippocampus, and the overexpression of VEGF induces angiogenesis and neurogenesis in the adult hippocampus. Accordingly, we noted that impairment of the morphology of astrocytes in the MDG subregion of the hippocampus inhibits VEGF signalling and this is one of the possible mechanisms underlying the impairment in neurogenesis and angiogenesis in depression. In contrast, ketamine by changing the morphology of astrocytes and consequently the function of astrocytes has a counter effect on the hippocampal microvasculature and neurogenesis. Looked at from another aspect, local vasoconstriction or vasodilator responses in the brain are triggered by neuronal activity, which is dependent on the glutamate-mediated [Ca 2+ ] oscillations in the astrocytes. Thus, another possible consequence of the morphological changes of astrocytes in depression is the impairment of activity-dependent vasodilatation as a result of inhibiting these Ca 2+ responses, which is reversed by ketamine treatment.
Our results support the hypothesis that the morphological impairment of hippocampal astrocytes contributes to the pathogenesis of depression. One of the mechanisms underlying the fast antidepressant effect of ketamine is its ability to modify the morphology of astrocytes, so that they can optimally modulate the synaptic micro-environment, neurogenesis and vascularization.
Create a free account to open full-text PDFs.